ACADIA PHARMACEUTICALS INC ($ACAD)
Filing Information
| Accession Number | 0001193125-26-253632 |
|---|---|
| Form Type | 4 |
| Filing Date | Jun 2, 2026 |
| Document | View SEC Filing |
Transactions
4
Total Shares
101,260
Total Value
$0.00
P&L
+inf% (+$2,551,752.00)
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Director | Common Stock | โ | May 29, 2026 | Grant/Award | 18,622 | $0.00 | $0.00 | 3,677,357 | Indirect | See Footnotes | View Details | |
Director | Common Stock | โ | May 29, 2026 | Grant/Award | 18,622 | $0.00 | $0.00 | 39,384,587 | Indirect | See Footnotes | View Details | |
Director | Non- Qualified Stock Option (right to buy) | Derivative | May 29, 2026 | Grant/Award | 32,008 | $0.00 | $0.00 | 32,008 | Indirect | See Footnotes | View Details | |
Director | Non- Qualified Stock Option (right to buy) | Derivative | May 29, 2026 | Grant/Award | 32,008 | $0.00 | $0.00 | 32,008 | Indirect | See Footnotes | View Details |